Partner of choice in pharmaceutical innovation

Tailor-made solutions for your requirements in pharmaceutical development

EXPLORE OUR SERVICES
Healthcare and Medicine

Product Profiling and Clinical Development

Specialised in high-level clinical development plans and registration

Closeup shot of a stethoscope resting on a laptop with an unrecognizable doctor working in the background

Medical Expertise and Key Opinion Leaders

Extensive experience in the area with access to a large number of experts and KOLs

Insurance agent checking policy documents in office.

Regulatory
Strategy

Assistance and support to access the EU and UK markets including Orphan Drugs and rare diseases

Medical team having a meeting in conference room in hospital

Advisory Services for Clinical Research

Assistance in clincal trials, studies and statistical evaluation

Various modern tablets are among a stack of different books. On a wooden background. The concept of knowledge. Close-up.

Reports, Results and
Publications

Data analysis and clinical reports, expert committees, KOL review and publication

Large bold word GMP - good manufacturing practice written in glowing white blue letters on black background. 3d illustration.

Audits and
Quality Assurance

Audits in GMP, GLP, GCP etc. Training for QA procedures and development of SOPs

Our commitment and experience in  pharmaceutical development make us your ideal partner

EXPLORE OUR HISTORY

Recent News

Kester Capital backs management buy-out of Rephine

Rephine is delighted to announce the purchase of the business via a management buy-out, by a team comprising the existing senior managers together with a ...
Read More →

Getting Ready for the Clinical Trial Regulation

It’s been a difficult year for many biopharma companies and perhaps even more so for clinical research organisations, with Covid-19 forcing the postponement or even ...
Read More →

Medical Devices Back in the Spotlight

The global disruption caused by the pandemic meant regulatory plans for 2020 needed to be delayed to give the life sciences industry and authorities breathing ...
Read More →

Data protection to take centre stage in 2021

In early December, the EMA announced that it had been hit by a cyber-attack and that documents related to the Pfizer-BioNTech Covid-19 vaccines had been ...
Read More →
MORE NEWS
Scroll to Top